Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Ingham

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Nucleic Acids Research|July 10, 2008
Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencingElizabeth D Wederell, Mikhail Bilenky, Rebecca Cullum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or LymphomasFunda Meric-Bernstam, Randy F Sweis, F Stephen Hodi, et al.
Microbial Genomics|November 27, 2023
Development of a novel streamlined workflow (AACRE) and database (inCREDBle) for genomic analysis of carbapenem-resistant EnterobacteralesTyler S Alioto, Marta Gut, Bruno Kotska Rodiño-Janeiro, et al.
BMC Genomics|June 4, 2013
Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factorFranc Llorens, Manuela Hummel, Lorena Pantano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2023
Correction: Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or LymphomasFunda Meric-Bernstam, Randy F Sweis, F Stephen Hodi, et al.
BMC Genomics|June 25, 2011
Multiple platform assessment of the EGF dependent transcriptome by microarray and deep tag sequencing analysisFranc Llorens, Manuela Hummel, Xavier Pastor, et al.
Cancers|March 6, 2021
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)Bernd Kasper, Annie Achee, Kathrin Schuster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Phase 1 and 2 Clinical Studies of the STING Agonist Ulevostinag With and Without Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors or LymphomasKevin J Harrington, Stephane Champiat, Joshua D Brody, et al.
Ebiomedicine|October 30, 2025
Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation studyJacob S Thomas, Lillian L Siu, Matthew Ingham, et al.
JCI Insight|February 22, 2022
Multiplexed single-cell analysis reveals prognostic and nonprognostic T cell types in human colorectal cancerKazuya Masuda, Adam Kornberg, Jonathan Miller, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Nucleic Acids Research|July 10, 2008
Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencingElizabeth D Wederell, Mikhail Bilenky, Rebecca Cullum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or LymphomasFunda Meric-Bernstam, Randy F Sweis, F Stephen Hodi, et al.
Microbial Genomics|November 27, 2023
Development of a novel streamlined workflow (AACRE) and database (inCREDBle) for genomic analysis of carbapenem-resistant EnterobacteralesTyler S Alioto, Marta Gut, Bruno Kotska Rodiño-Janeiro, et al.
BMC Genomics|June 4, 2013
Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factorFranc Llorens, Manuela Hummel, Lorena Pantano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2023
Correction: Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or LymphomasFunda Meric-Bernstam, Randy F Sweis, F Stephen Hodi, et al.
BMC Genomics|June 25, 2011
Multiple platform assessment of the EGF dependent transcriptome by microarray and deep tag sequencing analysisFranc Llorens, Manuela Hummel, Xavier Pastor, et al.
Cancers|March 6, 2021
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)Bernd Kasper, Annie Achee, Kathrin Schuster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Phase 1 and 2 Clinical Studies of the STING Agonist Ulevostinag With and Without Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors or LymphomasKevin J Harrington, Stephane Champiat, Joshua D Brody, et al.
Ebiomedicine|October 30, 2025
Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation studyJacob S Thomas, Lillian L Siu, Matthew Ingham, et al.
JCI Insight|February 22, 2022
Multiplexed single-cell analysis reveals prognostic and nonprognostic T cell types in human colorectal cancerKazuya Masuda, Adam Kornberg, Jonathan Miller, et al.
Pageof 4